A Study of DNIB0600A in Comparison With Pegylated Liposomal Doxorubicin (PLD) in Participants With Platinum-Resistant Ovarian Cancer (PROC)
Clinical trial NCT01991210 · TERMINATED
Trial details
- NCT number
- NCT01991210
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-06
- Primary completion
- 2016-08-17
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.